Evidence-based medicine in managed care: A survey of current and emerging strategies

MedGenMed Medscape General Medicine

Volumn 6, Issue 2, 2004, Pages

  Keckley, Paul H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS DEVELOPMENT; CONSUMER; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DOCTOR PATIENT RELATION; EMPLOYER; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HEALTH CARE PLANNING; HEART DISEASE; HUMAN; MANAGED CARE; MANAGED CARE ORGANIZATION; MEDICAL CARE; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PROSPECTIVE PAYMENT; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SECONDARY PREVENTION; SYSTEMATIC REVIEW; TRUST; ARTICLE; HEALTH INSURANCE; INFORMATION PROCESSING; UNITED STATES;

DATA COLLECTION; EVIDENCE-BASED MEDICINE; MANAGED CARE PROGRAMS; UNITED STATES;

EID: 8844235216     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Sackett DL, Rosenberg WM, Muir Gray JA, et al. Evidence-based medicine: what it is and what it isn't. BMJ. 1996;312:71.
2. The Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
3. Balas EA. Information technology and physician decision support. Program and abstracts of Accelerating Quality Improvement in Health Care: Strategies to Speed the Diffusion of Evidence-based Innovations, sponsored by National Committee for Quality Health Care; January 27-28, 2003; Washington DC.
4. Midwest Business Group on Health. Reducing the Costs of Quality Health Care Through Responsible Purchasing Leadership. Chicago, Ill: Midwest Business Group on Health; 2002.
5. Ignagni K. Commentary. Health Plan. 2002;43:3.
6. McGlynn EA, Asch SM, Adams J, et al. The quality of health care to adults in the United States. N Engl J Med. 2003;348:2635-2645.
7. Shortell S. Care, management practices going by the wayside. AAHP Smart Briefs. January 22, 2003.
8. Eisenberg JM. Quality research for quality healthcare: the data connection. Health Services Research. 2000;35:12-17.
9. Mechanic D. Bringing science to medicine: the origins of evidence-based medicine. Health Aff. 1998;17:250-251.
10. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. London: Churchill Livingstone; 2000.
11. Keckley PH, Heavrin B. Evidence-based medicine in medical education: a survey of top 25 schools of medicine. Vanderbilt Center for Evidence-Based Medicine. 2004; In press.
12. Muir Gray JA. Evidence-Based Medicine: How to Make Health Policy and Management Decisions. London: Churchill Press; 1997.
13. Field MJ, Lohrs KN. Guidelines for Clinical Practice: From Development to Use. Institute of Medicine. Washington, DC: National Academy Press; 1992.
14. Kemper DW, Mettler M. Information Therapy: Prescribed Information as a Reimbursable Medical Service. Boise, Idaho: Center for Information Therapy; 2002.
15. Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care. 2000;38:335.
16. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-776.
17. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361:653-661.
18. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101:653-661.
19. Un tzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-2845.
20. Kavanaugh A. Update on approved biologic therapies for rheumatoid arthritis. Advances in Targeted Biologic Therapy for Rheumatic Diseases. Program and abstracts of the 65th Annual Scientific Meeting of the American College of Rheumatology; November 11-15, 2001; San Francisco, California.
21. Kavanaugh A. Emerging biologic therapies for rheumatoid arthritis. Advances in Targeted Biologic Therapy for Rheumatic Diseases. Program and abstracts of the 65th Annual Scientific Meeting of the American College of Rheumatology; November 11-15, 2001; San Francisco, California.
22. Miller SB, Lynn K. Rheumatoid arthritis. In: Hurst JW, Ambrose SS, eds. Medicine for the Practicing Physician. 4th edition. Boston, Mass: Butterworth-Heinemann; 1996:209-214.
23. Ferraccioli GF, Valentini G, Valesini G, Bombardieri S. Reconstructing the treatment pyramid in rheumatoid arthritis: an urgent need. Clin Exp Rheumatol. 2001;19:621-624.
24. Cannella AC, O'Dell JR. Use of combination therapy for RA. J Musculoskeletal Med. 2003;20:162-172.
25. Yelin E, Herrndorf A, Trupin L, Sonneborn D. National study of the impact of health maintenance organizations on health care use by patients with rheumatoid arthritis. Arthritis Rheum. 2002;46(9 suppl):S94.
26. Yelin EH. Impact of managed care on use of new medications for RA. Arthritis Rheum. 2002;46(9 suppl):S626.
27. Hochberg MC, Tracy JK, Flores RH. A cost-minimization analysis based on a systematic review of randomized placebo-controlled trials of the addition of biologic agents to methotrexate in patients with active RA. Arthritis Rheum. 2002:46(9 suppl);S95.
28. Smith SC, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577-1579.
29. Snow V, Weiss KB, Nottur-Pilson C, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med. 2003;138:587-592.
30. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation. 2002;106:3143-3421.
31. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
32. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-259.